Developer docs
API playgroundTry for free, no card

Search company profiles

Principle Health Systems

Full company profile

uuid0008fjp

Namestring
Principle Health Systems
Websiteurl
principlehs.com
Company typeenum
Private
Founded yearint
2016
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersHouston, United States
HQ citystring
Houston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mobile diagnostic services, long-term care diagnostics, bedside laboratory testing, skilled nursing services, pharmacogenomic testing
Industry2 codes
PRIMARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
NAICS code2 codes
  • Medical and Diagnostic Laboratories6215
  • Medical and Diagnostic Laboratories62151
SIC code3 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Home Health Care Services8082
Product category
Mobile Diagnostic Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Mobile Laboratory and Diagnostic Services
TypeSubscription Recurring
Description

The company generates revenue by providing mobile laboratory and diagnostic services to long-term care facilities. Services include testing and imaging delivered at the bedside, eliminating the need for patient transport to offsite facilities. The acquisition strategy enhances these service capabilities.

prnewswire.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Principle Health Systems provides mobile laboratory and diagnostic services delivered directly to long-term care facilities. The company offers coordinated bedside testing and imaging services to skilled nursing and rehabilitation centers across the Southern and Central United States, eliminating the need for patient transport to offsite facilities. Its capabilities are augmented by acquired laboratory brands BioStat Laboratory and Telos PGx, providing enhanced laboratory and pharmacogenomic testing services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reduces need for patient transport to offsite facilities
+1 more record
Product overview1 text field

Principle Health Systems operates as a mobile laboratory and diagnostic services provider serving long-term care facilities across the Southern and Central United States. The company provides a unified platform of bedside diagnostic services, combining in-house capabilities with acquired laboratory assets (BioStat Laboratory, Telos PGx) and mobile diagnostic platforms. Their offering centers on delivering coordinated laboratory testing and diagnostic imaging directly to skilled nursing and rehabilitation centers, eliminating the need for patient transport to offsite facilities.

Product and service3 records
1Mobile Laboratory and Diagnostic Services
2BioStat Laboratory Services
3Telos PGx Pharmacogenomic Testing
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Regional-to-national clinical laboratory offering routine and specialty diagnostics (including PGx and molecular) to SNFs and physician practices; comparable on the lab-services side, though it lacks Principle's mobile-bedside orientation.

TypeBroad incumbent
Description

Diversified national clinical lab operator with established LTC and post-acute accounts; represents both an existing competitor for routine testing and a potential consolidator of regional mobile diagnostics platforms like Principle.

TypeDirect peer
Description

Mobile diagnostic and laboratory services provider focused on skilled nursing facilities and post-acute care, offering bedside phlebotomy, imaging, and pharmacy services — a direct analog to Principle Health Systems' bedside-diagnostics model.

TypeDirect peer
Description

Mobile diagnostic imaging and laboratory services provider focused on long-term care and post-acute facilities — overlapping end market (SNF/rehab) and bedside service model with Principle Health Systems.

TypeEmerging player
Description

Specialty clinical laboratory focused on pharmacogenomics, toxicology, and infectious disease testing serving similar provider and LTC-adjacent customer bases; comparable in specialty diagnostic menu to the PGx arm of Principle.

TypeBroad incumbent
Description

Global clinical laboratory operator with US operations serving skilled nursing and post-acute providers; competes for the same LTC diagnostic ordering and could acquire regional mobile operators to extend reach.

TypeDirect peer
Description

National mobile diagnostics provider serving LTC, SNF, and post-acute customers with mobile radiology, ultrasound, and laboratory services — the largest scaled pure-play in mobile diagnostics to the same LTC customer base.

TypeBroad incumbent
Description

One of the two dominant US clinical laboratory incumbents, already serving LTC operators from centralized labs and the most likely large-scale entrant into bedside mobile diagnostics if it chooses to vertically extend.

TypeEmerging player
Description

Pharmacogenomics (PGx) testing services provider — directly comparable to Principle Health Systems' Telos PGx subsidiary in modality, customer overlap (LTC and prescriber networks), and clinical use case.

TypeEmerging player
Description

Specialty diagnostics laboratory offering genetic and pharmacogenomic testing to clinicians; comparable on specialty/PGx test mix overlapping with Telos PGx, although primary channel is broader than LTC.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Principle Health Systems

Mobile Diagnostic Servicesprinciplehs.com

Principle Health Systems firmographics

Firmographics
Name
Principle Health Systems
Website
https://principlehs.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Principle Health Systems industry classification

Industry
Product category
Mobile Diagnostic Services
NAICS
Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Home Health Care Services (8082)
akta.pro industry
PRIMARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

Keywords

  • Mobile diagnostic services
  • Long-term care diagnostics
  • Bedside laboratory testing
  • Skilled nursing services
  • Pharmacogenomic testing

Where Principle Health Systems is headquartered

Location

Headquarters

HQ city
Houston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Principle Health Systems business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

  1. Mobile Laboratory and Diagnostic Services: The company generates revenue by providing mobile laboratory and diagnostic services to long-term care facilities. Services include testing and imaging delivered at the bedside, eliminating the need for patient transport to offsite facilities. The acquisition strategy enhances these service capabilities.

Go-to-market motion2 records

Distribution channels1 record

Principle Health Systems product offering

Product offering

Core offering

Principle Health Systems provides mobile laboratory and diagnostic services delivered directly to long-term care facilities. The company offers coordinated bedside testing and imaging services to skilled nursing and rehabilitation centers across the Southern and Central United States, eliminating the need for patient transport to offsite facilities. Its capabilities are augmented by acquired laboratory brands BioStat Laboratory and Telos PGx, providing enhanced laboratory and pharmacogenomic testing services.

Product overview

Principle Health Systems operates as a mobile laboratory and diagnostic services provider serving long-term care facilities across the Southern and Central United States. The company provides a unified platform of bedside diagnostic services, combining in-house capabilities with acquired laboratory assets (BioStat Laboratory, Telos PGx) and mobile diagnostic platforms. Their offering centers on delivering coordinated laboratory testing and diagnostic imaging directly to skilled nursing and rehabilitation centers, eliminating the need for patient transport to offsite facilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Mobile Laboratory and Diagnostic Services
  • BioStat Laboratory Services
  • Telos PGx Pharmacogenomic Testing

Quantifiable outcome

  • Reduces need for patient transport to offsite facilities
  • +1 more outcomes

Companies that use Principle Health Systems

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Principle Health Systems technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Principle Health Systems partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Principle Health Systems competitors and assessment

Company assessment

Broad incumbents

  • BioReference Laboratories: Regional-to-national clinical laboratory offering routine and specialty diagnostics (including PGx and molecular) to SNFs and physician practices; comparable on the lab-services side, though it lacks Principle's mobile-bedside orientation.
  • Quest Diagnostics: Diversified national clinical lab operator with established LTC and post-acute accounts; represents both an existing competitor for routine testing and a potential consolidator of regional mobile diagnostics platforms like Principle.
  • Sonic Healthcare USA: Global clinical laboratory operator with US operations serving skilled nursing and post-acute providers; competes for the same LTC diagnostic ordering and could acquire regional mobile operators to extend reach.
  • Labcorp: One of the two dominant US clinical laboratory incumbents, already serving LTC operators from centralized labs and the most likely large-scale entrant into bedside mobile diagnostics if it chooses to vertically extend.

Direct peers

  • Schryver Medical: Mobile diagnostic and laboratory services provider focused on skilled nursing facilities and post-acute care, offering bedside phlebotomy, imaging, and pharmacy services — a direct analog to Principle Health Systems' bedside-diagnostics model.
  • MobilexUSA: Mobile diagnostic imaging and laboratory services provider focused on long-term care and post-acute facilities — overlapping end market (SNF/rehab) and bedside service model with Principle Health Systems.
  • TridentUSA Health Services: National mobile diagnostics provider serving LTC, SNF, and post-acute customers with mobile radiology, ultrasound, and laboratory services — the largest scaled pure-play in mobile diagnostics to the same LTC customer base.

Emerging players

  • Aegis Sciences Corporation: Specialty clinical laboratory focused on pharmacogenomics, toxicology, and infectious disease testing serving similar provider and LTC-adjacent customer bases; comparable in specialty diagnostic menu to the PGx arm of Principle.
  • OneOme: Pharmacogenomics (PGx) testing services provider — directly comparable to Principle Health Systems' Telos PGx subsidiary in modality, customer overlap (LTC and prescriber networks), and clinical use case.
  • GeneDx: Specialty diagnostics laboratory offering genetic and pharmacogenomic testing to clinicians; comparable on specialty/PGx test mix overlapping with Telos PGx, although primary channel is broader than LTC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Principle Health Systems social profiles

Digital presence

Principle Health Systems financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Principle Health Systems leadership team

Management profile

Number of profiles

Profiles1 record

Principle Health Systems subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Principle Health Systems funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Principle Health Systems M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Principle Health Systems

What does Principle Health Systems do?

Principle Health Systems provides mobile laboratory and diagnostic services delivered directly to long-term care facilities. The company offers coordinated bedside testing and imaging services to skilled nursing and rehabilitation centers across the Southern and Central United States, eliminating the need for patient transport to offsite facilities. Its capabilities are augmented by acquired laboratory brands BioStat Laboratory and Telos PGx, providing enhanced laboratory and pharmacogenomic testing services.

Is Principle Health Systems a public or private company?

Principle Health Systems is a private company. It is classified as private equity controlled and is currently operating.

When was Principle Health Systems founded?

Principle Health Systems was founded in 2016. It employs 101 to 250 people.

Where is Principle Health Systems based?

Principle Health Systems is headquartered in Houston, United States, in the North America region.

How does Principle Health Systems make money?

One revenue line is on record: mobile Laboratory and Diagnostic Services.

Who are Principle Health Systems's main competitors?

Broad incumbents on record are BioReference Laboratories, Quest Diagnostics, Sonic Healthcare USA and Labcorp. Direct peers are Schryver Medical, MobilexUSA and TridentUSA Health Services. Emerging players are Aegis Sciences Corporation, OneOme and GeneDx.

Does Principle Health Systems have an API?

No public API is recorded for Principle Health Systems.

What industry is Principle Health Systems in?

Principle Health Systems's product category is Mobile Diagnostic Services. Its primary akta.pro industry code is HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices), with a secondary code of HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireAcquisition expands Principle's bedside imaging services for long-term care providers in Missouri and IllinoisPrinciple Health Systems acquired select assets from a mobile diagnostic imaging company serving the St. Louis, Missouri area, extending its bedside imaging services. The deal adds portable X-ray, ultrasound, and EKG capabilities for long-term care partners, with technologists and equipment. Principle aims for a seamless transition with no interruption in care.Pulse 2.0Principle Health Systems Strengthens Mobile Diagnostics Platform Through Strategic Asset AcquisitionPrinciple Health Systems announced the acquisition of select assets from a mobile diagnostic services company to expand its mobile laboratory and diagnostic service capabilities for long-term care facilities across the Southern and Central United States. The transaction is designed to strengthen operational capabilities, reduce the need for patient transport to offsite facilities, and position the company as a single-source diagnostic partner for skilled nursing and rehabilitation centers. CEO James Dieter stated the acquisition reflects the company's continued commitment to making high-quality testing and imaging resources more accessible at the bedside for long-term care residents.AijournPrinciple Health Systems Strengthens Mobile Diagnostic Platform Through Strategic Asset AcquisitionPrinciple Health Systems, a provider of mobile laboratory and diagnostic services to long-term care facilities in the Southern and Central US, announced the acquisition of assets from a mobile diagnostic services company. This strategic move aims to enhance their ability to deliver bedside diagnostic services, support clinical decision-making, and simplify workflows.PR NewswirePrinciple Health Systems Strengthens Mobile Diagnostic Platform Through Strategic Asset AcquisitionPrinciple Health Systems, a major provider of mobile laboratory and diagnostic services to long-term care facilities, announced the strategic acquisition of select assets from a mobile diagnostic services company on June 4, 2026. The transaction enhances the company's ability to deliver coordinated bedside diagnostic services across its Southern and Central US footprint, reducing the need for patient transport to external facilities. The acquisition is part of Principle's broader strategy to expand its diagnostic platform and deepen support for long-term care partners.InsideprecisionmedicineFive Startups Surfing the PGx WaveThis article profiles five pharmacogenomics startups—GenXys, Kadance, NeuroKaire, PGxAI, and Stalicla—as investor interest in the sector grows amid projected market expansion from $7.6 billion in 2024 to $12.4 billion by 2030, with AI tools in the space expected to surge at 23.9% annually to $12.6 billion by 2033. The featured startups have collectively raised over $85 million in recent funding rounds and include acquisitions such as Kadance's purchase of Kailos Genetics and partnerships like NeuroKaire's collaboration with NeuroSense Therapeutics for Alzheimer's drug development. Stalicla notably advanced its autism spectrum disorder candidate STP1 to Phase II, while the broader M&A landscape saw Telos PGx acquired by Principle Health Systems and Corriel Life Sciences by InformedDNA.Pulse 2.0Principle Health Systems Buying Heartland Health LaboratoryPrinciple Health Systems acquired Heartland Health Laboratory, a CLIA-certified clinical diagnostics company based outside Kansas City. The deal expands PHS's Midwest presence and integrates Heartland's full-service laboratory into its network. PHS will invest in Heartland's team, technology, and operations to enhance patient services.InvestorshangoutPrinciple Health Systems Boosts Diagnostic Services in the MidwestPrinciple Health Systems acquired Heartland Health Laboratory to expand its diagnostic network in the Midwest. The CLIA-certified lab, founded in 2004, brings 20 years of experience and a patient-centric approach. PHS plans to invest in Heartland's team and technology to improve service delivery.PR NewswirePrinciple Health Systems Acquires Heartland Health Laboratory, Expanding Diagnostic Capabilities in the MidwestPrinciple Health Systems acquired Heartland Health Laboratory, a CLIA-certified, high-complexity laboratory in Lenexa, Kansas, to expand its Midwest presence. The acquisition aims to enhance diagnostic services for long-term care facilities, with CEO James Dieter citing investment in team, technology, and operations.BenzingaPrinciple Health Systems Acquires Telos PGX: A Strategic Move to Advance Personalized HealthcarePrinciple Health Systems acquired Telos PGX, a pharmacogenetic testing provider for skilled nursing facilities. D.J. Hart will join Principle's leadership as Director of Pharmacogenetic Operations. The deal aims to accelerate personalized medicine adoption and improve patient outcomes.FinSMEsPrinciple Health Systems Acquires BioStat ImagingPrinciple Health Systems acquired BioStat Imaging, a mobile imaging provider, with the deal amount undisclosed. The acquisition will give Principle a one-stop solution for laboratory and imaging services in long-term care facilities.